| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David L Barker is Director at BNGO. David L Barker's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $70K at current prices.
Net of sales, the BNGO filings show accumulation of 13,894 shares.
David L Barker has 12 Form 4 filings on record from August 2018 to May 2026, all as Director at Bionano Genomics (BNGO), 2018–2026.
The 14 reported transactions were 10 option or other derivative awards, 3 open-market purchases and 1 option exercise.
Counted by filing, the open-market trades come to 2 purchases worth about $41K and no sales.
The largest open-market purchase was 3,894 shares of BNGO at an average $6.47 on August 21, 2018, about $25K.